UAE Radiotherapy Market Report 2022 to 2030

UAE Radiotherapy Market Analysis

$ 3999

By 2030, it is anticipated that the UAE Radiotherapy Market will reach a value of $59 Mn from $35 Mn in 2022, growing at a CAGR of 7% during 2022-2030. The Radiotherapy Therapeutics Market in UAE is dominated by a few domestic players such as Elekta, IBA Proton Therapy, and Elekta. The radiotherapy market in UAE is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for UAE Radiotherapy is increasing on account of the rise in cancer cases in the country.

ID: IN10AEPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: UAE AUTHOR: Dr. Vishwa Modhia

Buy Now

UAE Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the UAE Radiotherapy Market will reach a value of $59 Mn from $35 Mn in 2022, growing at a CAGR of 7% during 2022-30.

United Arab Emirates (UAE) is a high-income, developing country located in the Middle East bordering the Gulf of Oman and the Persian Gulf. Cancer is the third leading cause of death in the UAE; cancer care in the UAE has grown dramatically over the previous 40 years, from a single centre in Al Ain in 1981 to more than 30 cancer centres and clinics around the UAE today, including at least four comprehensive cancer facilities.

In 2019, the UAE National Cancer Registry (UAENCR) received 4633 reports of newly diagnosed cancer cases (both malignant and non-malignant). Breast, thyroid, colorectal, skin, and leukaemia were the top five cancer types in both sexes. The Emirates Oncology Society (EOS) is the UAE's official organisation representing oncology healthcare providers. UAE's government spent 5.5% of its GDP on healthcare in 2020.

UAE Radiotherapy Market Analysis

Market Dynamics

Market Growth Drivers Analysis

The United Arab Emirates is one of the top locations in the world for persons seeking high-quality Radiation Therapy. The UAE is a centre for modern healthcare services and high-quality medical care. The country has highly experienced doctors and medical support professionals. In the United Arab Emirates, there are numerous hospitals and clinics that provide radiation therapy treatment. The visa application process for overseas patients in the UAE is quick and straightforward. The hospitals help with the process by providing expedited visa invitation letters. These aspects could boost UAE Radiotherapy Market.

Market restraints

Radiotherapy is an expensive treatment in the UAE. In the United Arab Emirates, the average cost of intensity-modulated radiotherapy (IMRT) ranges between $21,000 and $366,901. Stereotactic Radiotherapy begins at $14,440 in Dubai. Despite substantial advances in medical care, cancer quality control in the UAE remains poor, with major variations in cancer care between cancer centres. Access to clinical trials is still limited due to a lack of competence and research infrastructure, as well as a tiny population, making patient recruitment difficult. These factors may deter new entrants into the UAE Radiotherapy Market.

Competitive Landscape

Key Players

Gulf Healthcare International (GHI): Based in Dubai, GHI is a leading supplier of medical equipment and services in the Middle East, including radiotherapy equipment
Elekta: Elekta is a Swedish company with a strong presence in the UAE, offering advanced radiotherapy solutions for cancer treatment
Varian Medical Systems: Varian is a global leader in radiotherapy and radiation oncology solutions, with a significant presence in the UAE
Siemens Healthineers: Siemens Healthineers is a German multinational medical equipment and services company that provides radiotherapy equipment and solutions in the UAE
Accuracy: Accuracy is a US-based company that offers innovative radiation therapy solutions for cancer treatment, including the CyberKnife system, which is available in the UAE
IBA Proton Therapy: IBA Proton Therapy is a Belgian company that provides advanced proton therapy solutions for cancer treatment, with a presence in the UAE

Healthcare Policies and Reimbursement Scenarios

The Federal Authority for Nuclear Regulation (FANR) is responsible for regulating radiation safety in the UAE. FANR issues licenses and permits to authorize entities to conduct regulated activities using regulated materials for medical and non-medical fields in accordance with FANR’s regulations. In the United Arab Emirates (UAE), radiotherapy is regulated by the Dubai Health Authority (DHA), the Health Authority Abu Dhabi (HAAD), and the Ministry of Health and Prevention (MOHAP).

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.